Clinical Trials

Showing trials with last updates posted in 2022.

NCT02705755 | COMPLETED | PHASE2
34 participants

TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Study Type:
INTERVENTIONAL
Last Updated:
2022-09-26
Start Date:
2017-09-09
Completion:
2018-07-24
Conditions
  • Neurogenic Orthostatic Hypotension
  • Multiple System Atrophy (MSA) With Orthostatic Hypotension
  • Pure Autonomic Failure
  • Parkinson Disease
  • Hypotension, Orthostatic
  • Orthostatic Hypotension
  • Pure Autonomic Failure With Orthostatic Hypotension
  • Parkinson Disease With Orthostatic Hypotension
Interventions
  • DRUG
NCT02230969 | COMPLETED
1208 participants

Plegridy Observational Program

Study Type:
OBSERVATIONAL
Last Updated:
2022-09-26
Start Date:
2014-11-12
Completion:
2022-01-20
Conditions
  • Relapsing Forms of Multiple Sclerosis
Interventions
  • DRUG
No Results Yet
NCT01886859 | COMPLETED | PHASE1
27 participants

Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2022-09-26
Start Date:
2013-04-26
Completion:
2020-11-15
Conditions
  • Recurrent B-Cell Prolymphocytic Leukemia
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory B-Cell Prolymphocytic Leukemia
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Small Lymphocytic Lymphoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page